Skip to main content
OpenTrials
Completed

NCT Number: NCT01917513

Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy

The purpose of this study is to compare the adenoma detection rate of G-EYE™ high definition colonoscopy with that of standard high definition colonoscopy

Completed

Looking for future studies?

Notify Me

Key information

About this study

This is a multicenter, two-arm, randomized, open-label study intended to compare the detection rate obtained by performing G-EYE™ high definition colonoscopy vs. the detection rate obtained by performing high definition standard colonoscopy.

The study will enroll 1000 subjects. Consecutive adult subjects who were referred for elective colonoscopy will be asked to enroll into this randomized clinical study if the candidate meets the study inclusion and exclusion criteria.

Subjects will sign informed consent form and undergo randomization. The study includes a run-in preliminary phase of 270 patients to allow physicians to get familiar with the G-EYE™ endoscope.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over 50 years old
  • Referred to colonoscopy for screening, following positive FOBT testing, change of bowel habits or for surveillance colonoscopy (history of adenoma resection).
  • The patient must understand and provide written consent for the procedure.

Exclusion criteria

  • Subjects with inflammatory bowel disease;
  • Subjects with a personal history of polyposis syndrome;
  • Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
  • Subjects with diverticulitis or toxic megacolon;
  • Subjects with a history of radiation therapy to abdomen or pelvis;
  • Pregnant or lactating female subjects;
  • Subjects who are currently enrolled in another clinical investigation.
  • Subjects with current oral or parenteral use of anticoagulants
  • Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
  • Any patient condition deemed too risky for the study by the investigator
  • Previous colonic surgery (except for appendectomy)

Treatment and study plan

G-EYE™ colonoscopy

Device

G-EYE™ colonoscopy

Standard Colonoscopy

Device

Standard Colonoscopy

Primary outcomes

  1. Detection Rate of Adenomas and Serrated Lesions

    Time frame: Approximalty following 14 days (histology results)

    The percentage of patients with at least one adenoma or serrated lesion in the G-EYE™ group will be compared to the Standard group

Secondary outcomes

  1. Number of Polyp and Adenoma Detection, Procedure Times and Safety (Number of Patients With Adverse Events.

    Time frame: Up to 14 days (histology results)

    The secondary outcome is a composite-each of the measured parameters will be reported as a single value for each arm

Sponsors and collaborators

Lead sponsor

Smart Medical Systems Ltd.

Industry

Registry information

Official study title

Prospective Randomized Trial to Compare the Clinical Efficiency (Adenoma Detection Rate) of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Aug 6, 2013
Registry last updated
Jan 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.